July 1, 2021

Solosec Receives Indication to Treat Common Sexually Transmitted Infection

Read More
July 1, 2021

Merck Announces Plan to Withdraw Keytruda’s Monotherapy Indication for PD-L1 Positive Gastric and GEJ Cancer

Read More
July 1, 2021

Brand Medications with Generic Alternatives Anticipated to be Approved in August

Read More
June 30, 2021

Teva Recalls Topotecan Injection to Retail/Institutional Level

Read More
June 30, 2021

Rylaze Approved to Treat ALL and LBL in Patients Allergic to E. Coli-Derived Chemotherapy Component

Read More
June 29, 2021

Restylane Contour Approved for Cheek Augmentation and Correction of Midface Contour Deficiencies in Adults

Read More
June 29, 2021

Restylane Contour Approved for Cheek Augmentation and Correction of Midface Contour Deficiencies in Adults

Read More
June 15, 2021

Rezipres Approved to Treat Hypotension in Patients Under Anesthesia

Read More
June 11, 2021

Two Lots of Metformin Recalled Due to NDMA

Read More
May 28, 2021

Zipsor Indication Expanded to Include Adolescent Patients

Read More
March 10, 2021

Fotivda Approved to Treat Renal Cell Carcinoma

Read More
March 1, 2021

Small Cell Lung Cancer Indications Withdrawn for Keytruda, Opdivo

Read More